Form N-PX - Annual Report of proxy voting record of management investment companies

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form N-PX - Annual Report of proxy voting record of management investment companies

Tri Continental (NYSE:TY-)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Tri Continental Charts.

Tri Continental (NYSE:TY-)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Tri Continental Charts.

Tri Continental Corp News

Form N-CSRS - Certified Shareholder Report, Semi-Annual
Thursday 5 September 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 4 September 2024 (3 weeks ago) • Edgar (US Regulatory)

Form N-PX - Annual Report of proxy voting record of management investment companies
Tuesday 3 September 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]
Thursday 18 July 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 2 March 2024 (7 months ago) • Edgar (US Regulatory)

Form N-CSR - Certified Shareholder Report
Saturday 2 March 2024 (7 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Saturday 2 March 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 19 January 2024 (8 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 17 January 2024 (8 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 17 January 2024 (8 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 11 January 2024 (9 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 3 January 2024 (9 months ago) • Edgar (US Regulatory)

More Tri Continental Corp News Articles

Qualigen Therapeutics

Accretion Acquisition

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions